300677 Stock Overview
Engages in the research and development, production, and marketing of medical consumables, health care equipment, and physiotherapy care products that are used in medical and elderly care institutions, household daily use, and other related industries in China and internationally. More details
Snowflake Score | |
---|---|
Valuation | 3/6 |
Future Growth | 4/6 |
Past Performance | 3/6 |
Financial Health | 4/6 |
Dividends | 1/6 |
Rewards
Risk Analysis
My Notes
Capture your thoughts, links and company narrative
Intco Medical Technology Co., Ltd. Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | CN¥27.07 |
52 Week High | CN¥33.61 |
52 Week Low | CN¥17.20 |
Beta | 0.80 |
1 Month Change | 1.50% |
3 Month Change | 24.75% |
1 Year Change | 18.94% |
3 Year Change | -44.06% |
5 Year Change | 357.38% |
Change since IPO | 397.88% |
Recent News & Updates
Intco Medical Technology (SZSE:300677) Seems To Use Debt Quite Sensibly
Nov 25There May Be Underlying Issues With The Quality Of Intco Medical Technology's (SZSE:300677) Earnings
Nov 04Recent updates
Intco Medical Technology (SZSE:300677) Seems To Use Debt Quite Sensibly
Nov 25There May Be Underlying Issues With The Quality Of Intco Medical Technology's (SZSE:300677) Earnings
Nov 04Intco Medical Technology (SZSE:300677) Seems To Use Debt Quite Sensibly
Aug 19Intco Medical Technology Co., Ltd. (SZSE:300677) Looks Inexpensive But Perhaps Not Attractive Enough
Jul 15Capital Allocation Trends At Intco Medical Technology (SZSE:300677) Aren't Ideal
May 21Intco Medical Technology (SZSE:300677) Posted Healthy Earnings But There Are Some Other Factors To Be Aware Of
May 02Intco Medical Technology Co., Ltd.'s (SZSE:300677) Business Is Trailing The Market But Its Shares Aren't
Mar 28Shareholder Returns
300677 | CN Medical Equipment | CN Market | |
---|---|---|---|
7D | -2.5% | -3.3% | -2.6% |
1Y | 18.9% | -10.4% | 9.7% |
Return vs Industry: 300677 exceeded the CN Medical Equipment industry which returned -9% over the past year.
Return vs Market: 300677 exceeded the CN Market which returned 11.3% over the past year.
Price Volatility
300677 volatility | |
---|---|
300677 Average Weekly Movement | 12.0% |
Medical Equipment Industry Average Movement | 8.5% |
Market Average Movement | 8.7% |
10% most volatile stocks in CN Market | 12.8% |
10% least volatile stocks in CN Market | 5.8% |
Stable Share Price: 300677's share price has been volatile over the past 3 months compared to the CN market.
Volatility Over Time: 300677's weekly volatility (12%) has been stable over the past year, but is still higher than 75% of CN stocks.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
2009 | 10,939 | Qiong Chen | www.intcomedical.com.cn |
Intco Medical Technology Co., Ltd. engages in the research and development, production, and marketing of medical consumables, health care equipment, and physiotherapy care products that are used in medical and elderly care institutions, household daily use, and other related industries in China and internationally. The company offers gloves; face masks and shields; ECG electrode comprising monitoring and diagnostic ECG, stress test and holter, pre-wired neonatal, tens, and off-set ECG electrodes; apparels, such as isolation gowns; hand sanitizer gel and spray; grounding pads; electrosurgical pencil; and ESU cables and tip cleaner. It also provides wheelchairs, scooters, and other rehabilitation and medical equipment; hot and cold products, emergency treatment products, and mother and baby products; and home care and cold chain products.
Intco Medical Technology Co., Ltd. Fundamentals Summary
300677 fundamental statistics | |
---|---|
Market cap | CN¥17.37b |
Earnings (TTM) | CN¥739.61m |
Revenue (TTM) | CN¥8.98b |
23.5x
P/E Ratio1.9x
P/S RatioIs 300677 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
300677 income statement (TTM) | |
---|---|
Revenue | CN¥8.98b |
Cost of Revenue | CN¥7.09b |
Gross Profit | CN¥1.88b |
Other Expenses | CN¥1.14b |
Earnings | CN¥739.61m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
Earnings per share (EPS) | 1.15 |
Gross Margin | 20.96% |
Net Profit Margin | 8.24% |
Debt/Equity Ratio | 78.3% |
How did 300677 perform over the long term?
See historical performance and comparisonDividends
0.4%
Current Dividend Yield12%
Payout RatioCompany Analysis and Financial Data Status
Data | Last Updated (UTC time) |
---|---|
Company Analysis | 2024/12/17 02:35 |
End of Day Share Price | 2024/12/17 00:00 |
Earnings | 2024/09/30 |
Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
Package | Data | Timeframe | Example US Source * |
---|---|---|---|
Company Financials | 10 years |
| |
Analyst Consensus Estimates | +3 years |
|
|
Market Prices | 30 years |
| |
Ownership | 10 years |
| |
Management | 10 years |
| |
Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Intco Medical Technology Co., Ltd. is covered by 5 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
Analyst | Institution |
---|---|
Yi Liu | Citic Securities Co., Ltd. |
Xiao Wei Lin | Everbright Securities Co. Ltd. |
Lingfei Kong | Huatai Research |